Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees" or the "Company"), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced that three ...
FDA has until May 25, 2026 to object to the notification, after which the Company will be free to market its proposed dietary supplement ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results